JBCHEPHARM — J B Chemicals and Pharmaceuticals Share Price
0.000.00%
Last trade - 00:00- IN₹276.18bn
- IN₹276.24bn
- IN₹31.49bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 39.39 | ||
| PEG Ratio (f) | 2.06 | ||
| EPS Growth (f) | 23.64% | ||
| Dividend Yield (f) | 0.52% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 10.17 | ||
| Price to Tang. Book | 20.25 | ||
| Price to Free Cashflow | 95.61 | ||
| Price to Sales | 8.16 | ||
| EV to EBITDA | 32.03 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 23.22% | ||
| Return on Equity | 20.43% | ||
| Operating Margin | 21.66% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 16,432 | 17,747.29 | 20,425.22 | 24,242.44 | 31,492.83 | 35,037.5 | 40,616.3 | 17.36% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +42.92 | +49.04 | +51.99 | -6.22 | +5.56 | +39.64 | +23.64 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its therapeutic categories include gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives and pharmacovigilance. The Company's lozenges products include center-filled, soft-centered lozenges; center-filled, powder lozenges; herbal lozenges, and medicated lozenges. The Company offers a complete range of contrast media products including X-ray, MRI, and ultrasound in India as well as internationally. The Company produces a wide range of dosage forms, such as tablets, capsules, liquids, IV infusions, ampoules, vials, ointments, cold rubs, lozenges and sips. Its brands include Rantac OD, RD, Ranraft, Metrogyl ER, Metrogyl O, Nicardia XL, Sporlac EVA and Sporlac G, among others.
Directors
- Pranabh Mody PRE (51)
- Nikhil Chopra CEO (47)
- Mayur Mehta CCO
- Bharat Mehta EDR (66)
- Shirish Mody EDR (72)
- Kamlesh Udani EDR (60)
- Ajay Candade NED
- Krupa Gandhi IND
- Manoj Mashru IND
- Shaukat Merchant IND
- Satyanarain Agarwala NID
- Rajiv Mody NID
- Devang Shah NID
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 18th, 1976
- Public Since
- February 2nd, 1995
- No. of Shareholders
- 57,909
- No. of Employees
- 5,095
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 155,194,800
- Address
- Cnergy It Park, Appa Saheb Marathe Marg, MUMBAI, 400025
- Web
- https://jbpharma.com/
- Phone
- +91 2224395200
- Auditors
- Deloitte Haskins & Sells LLP
Upcoming Events for JBCHEPHARM
Q1 2025 J B Chemicals and Pharmaceuticals Ltd Earnings Release
J B Chemicals and Pharmaceuticals Ltd Annual Shareholders Meeting
Similar to JBCHEPHARM
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
What is the J B Chemicals and Pharmaceuticals share price?
As of Today at 19:11 UTC, shares in J B Chemicals and Pharmaceuticals are trading at IN₹1,779.60. This share price information is delayed by 15 minutes.
How has the J B Chemicals and Pharmaceuticals share price performed this year?
Shares in J B Chemicals and Pharmaceuticals last closed at IN₹1,779.60 and the price had moved by +68.67% over the past 365 days. In terms of relative price strength the J B Chemicals and Pharmaceuticals share price has outperformed the S&P BSE 100 Index by +30.82% over the past year.
What are the analyst and broker recommendations for J B Chemicals and Pharmaceuticals?
The overall consensus recommendation for J B Chemicals and Pharmaceuticals is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the J B Chemicals and Pharmaceuticals dividend yield?
The J B Chemicals and Pharmaceuticals dividend yield is 0.57% based on the trailing twelve month period.
Does J B Chemicals and Pharmaceuticals pay a dividend?
Last year, J B Chemicals and Pharmaceuticals paid a total dividend of IN₹10.13, and it currently has a trailing dividend yield of 0.57%. We do not have any data on when J B Chemicals and Pharmaceuticals is to next pay dividends.
When does J B Chemicals and Pharmaceuticals next pay dividends?
We do not have data on when J B Chemicals and Pharmaceuticals is to next pay dividends. The historic dividend yield on J B Chemicals and Pharmaceuticals shares is currently 0.57%.
How do I buy J B Chemicals and Pharmaceuticals shares?
To buy shares in J B Chemicals and Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of J B Chemicals and Pharmaceuticals?
As of the previous close price of IN₹1,779.60, shares in J B Chemicals and Pharmaceuticals had a market capitalisation of IN₹276.18bn.
Where are J B Chemicals and Pharmaceuticals shares listed?
Here are the trading details for J B Chemicals and Pharmaceuticals:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: JBCHEPHARM
What kind of share is J B Chemicals and Pharmaceuticals?
Based on an overall assessment of its quality, value and momentum J B Chemicals and Pharmaceuticals is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a J B Chemicals and Pharmaceuticals share price forecast for 2024?
The analyst consensus target price for shares in J B Chemicals and Pharmaceuticals is IN₹1,742.46. That is 2.09% below the last closing price of IN₹1,779.60.
Analysts covering J B Chemicals and Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of IN₹36.54 for the next financial year.
What is the trend in the J B Chemicals and Pharmaceuticals share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like J B Chemicals and Pharmaceuticals. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +13.02%.
As of the last closing price of IN₹1,779.60, shares in J B Chemicals and Pharmaceuticals were trading +19.18% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the J B Chemicals and Pharmaceuticals PE Ratio?
The J B Chemicals and Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 39.39. The shares last closed at IN₹1,779.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of J B Chemicals and Pharmaceuticals?
J B Chemicals and Pharmaceuticals' management team is headed by:
- Pranabh Mody - PRE
- Nikhil Chopra - CEO
- Mayur Mehta - CCO
- Bharat Mehta - EDR
- Shirish Mody - EDR
- Kamlesh Udani - EDR
- Ajay Candade - NED
- Krupa Gandhi - IND
- Manoj Mashru - IND
- Shaukat Merchant - IND
- Satyanarain Agarwala - NID
- Rajiv Mody - NID
- Devang Shah - NID